Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Circulation: Heart Failure, 2025
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial

Topriceanu C., Vissing C., Axelsson Raja A. et al.

Olink Explore 3072/384CVDPathophysiologyPatient StratificationBlood

ESC Heart Failure, 2025
GEO combined with quantitative protein trait loci identify causative proteins in hypertrophic cardiomyopathy

Li B., Zhao X., Ding Y. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Cardiorenal Medicine, 2025
Biomarkers associated with worsening renal function and progression in chronic kidney disease among patients hospitalized for acute heart failure

Ohlsson M., Molvin J., Holm Isholth H. et al.

Olink Target 96CVDNephrologyPatient StratificationPlasma

Therapeutic Advances in Endocrinology and Metabolism, 2025
Multi-omics investigation of prospective therapeutic targets for type 1 diabetes

Zhang Y., Qiao Q., Chen B. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Journal of Inflammation Research, 2025
Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies

Zhang Y., Hu W., Li T. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Cardiovascular Research, 2025
Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study—differences and similarities

Fall T., Gummesson A., Hammar U. et al.

Olink Target 96CVDPatient StratificationPlasma

International Journal of Molecular Sciences, 2025
Unraveling the COVID-19 Severity Hubs and Interplays in Inflammatory-Related RNA–Protein Networks

Park H., Wang Q., Hasegawa T. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyBlood

Molecular Neurobiology, 2025
Uncovering Potential Susceptibility Genes for Multiple Sclerosis-Induced Neuropathic Bladder: A Mendelian Randomization Analysis

Xu Y., Xiong J., Wu Y. et al.

Olink Explore 3072/384NeurologyUrologyPathophysiologyPlasma

The Journal of Nutrition, 2025
Metabolomic and Proteomic Signatures of Ultra-processed Foods Are Positively Associated with Adverse Liver Outcomes

Zhao L., Chen Y., Clay-Gilmour A. et al.

Olink Explore 3072/384Metabolic DiseasesNutritional SciencePathophysiologyPlasma

Journal of the American College of Cardiology, 2025
Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure

Ferreira J., Anker S., Butler J. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

BMC Pregnancy and Childbirth, 2025
Sleeping for two: a cross-sectional study on associations between objectively measured sleep during early to mid-pregnancy and maternal and fetal outcomes and inflammatory biomarker profiles

Macdonald C., Pitsillos T., Wikström A. et al.

Olink Target 96ObstetricsPathophysiologyPlasma

International Immunopharmacology, 2025
The interplay between systemic inflammation and myopia: A bidirectional Mendelian randomization and experimental validation study

Huang Z., Zhou J., Liu S. et al.

Olink Target 96Olink Explore 3072/384OphthalmologyPathophysiologyPlasma

Journal of Advanced Research, 2025
Plasma proteomics identify novel biomarkers and dynamic patterns of biological aging

Ma L., Liu W., He Y. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

Discover Oncology, 2025
Integrating analysis of multi-omics summary data identifies novel plasma protein biomarkers and drug targets for bladder cancer

Cao J., Chen S., Wang J. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Scientific Reports, 2025
Profiling 92 circulating neurobiological proteins identifies novel candidate biomarkers of long-term cognitive outcome after ischemic stroke

Lagging C., Pedersen A., Petzold M. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Journal of Neurochemistry, 2025
IgD‐CD38‐B Cell Partially Mediates the Protective Effect of Higher Serum Triacylglycerol (53:4) Levels Against Parkinson's Disease

Jing Y., Zhu H., Yao P. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Biomarker Research, 2025
The overlooked trio: sleep duration, sampling time and physical exercise alter levels of olink-assessed blood biomarkers of cardiovascular risk

Brandão L., Zhang L., Grip A. et al.

Olink Target 96CVDTechnical EvaluationSerum

Neurobiology of Disease, 2025
Proximity extension assay reveals serum inflammatory biomarkers in two amyotrophic lateral sclerosis cohorts

Chen Y., Sun S., Gao N. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationSerum

Alzheimer's & Dementia, 2025
Exploring inflammation‐related protein expression and its relationship with TSPO PET in Alzheimer's disease

Pola I., Ashton N., Antônio De Bastiani M. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasmaCSF

Frontiers in Medicine, 2025
Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure mice

Baker J., Daly L., Hassibi S. et al.

Olink Target 96Respiratory DiseasesPathophysiologyCell Culture Supernatant

3026 publications